<DOC>
	<DOCNO>NCT00391196</DOCNO>
	<brief_summary>The purpose study determine CP-945,598 effective treatment obesity type 2 diabetic patient .</brief_summary>
	<brief_title>A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients</brief_title>
	<detailed_description>The CP-945,598 program terminate November 3 , 2008 due change regulatory perspective risk/benefit profile CB1 class likely new regulatory requirement approval . No safety issue involve termination decision .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Subjects must overweight ( BMI 27 50 kg/m2 ) Subjects must type 2 diabetes mellitus Pregnancy Serious unstable current past medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>